# Repligen Corp: Form 8-K, filed Oct 30, 2026

- Company: [Repligen Corp](/companies/rgen.md) (CIK 730272)
- Form: 8-K
- Filed: 2026-10-30
- Accepted by EDGAR: Oct 30, 2026, 06:04 ET
- Period: 2026-10-29
- Accession: 0001628280-26-068382
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/730272/000162828026068382/rgen-20261029.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/730272/000162828026068382/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/730272/000162828026068382/rgen-20261029.htm

Filed Oct 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-068382. Last ingested by Listed: Nov 4, 2026, 22:02 ET. No prices; not investment advice.
